These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32484112)

  • 1. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
    Higashiyama S; Yoshida A; Kawabe J
    Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7.
    Ebrahim T; Hadebe B; Aldous C; Tinarwo P; Nyakale N
    Medicine (Baltimore); 2022 Jun; 101(25):e29515. PubMed ID: 35758394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computer program to assess the bone scan index for Tc-99m hydroxymethylene diphosphonate: evaluation of jaw pathologies of patients with bone metastases using SPECT/CT.
    Ogawa R; Ogura I
    Diagn Interv Radiol; 2023 Jan; 29(1):190-194. PubMed ID: 36960615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flare phenomenon visualized by
    Zhang X; Nakajima K; Mizokami A; Horikoshi H; Nishimoto K; Hashine K; Matsuyama H; Takahashi S; Wakabayashi H; Kinuya S
    Ann Nucl Med; 2024 Jun; 38(6):428-440. PubMed ID: 38478154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a software for semi-automatically calculating the bone scan index on bone scintigraphy scans.
    Yoshida A; Higashiyama S; Kawabe J
    Clin Imaging; 2021 Oct; 78():14-18. PubMed ID: 33714920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of
    Zhang Y; Lin Z; Li T; Wei Y; Yu M; Ye L; Cai Y; Yang S; Zhang Y; Shi Y; Chen W
    Sci Rep; 2022 Sep; 12(1):15993. PubMed ID: 36163353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer.
    Saylor PJ; Mahmood U; Kunawudhi A; Smith MR; Palmer EL; Michaelson MD
    J Nucl Med; 2012 Nov; 53(11):1670-5. PubMed ID: 22984218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.
    Tenenbaum F; Schlumberger M; Bonnin F; Lumbroso J; Aubert B; Benali H; Parmentier C
    Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of
    Oya T; Ichikawa Y; Nakamura S; Tomita Y; Sasaki T; Inoue T; Sakuma H
    Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
    Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
    J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between tumor volume and quantitative values calculated using two-dimensional bone scan images.
    Hosokawa S; Inoue K; Takahashi Y; Kawakami K; Kano D; Nakagami Y; Fukushi M
    Radiol Phys Technol; 2017 Dec; 10(4):496-506. PubMed ID: 28983807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraindividual Comparison of
    Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
    Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
    Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.